Phosphatase, tyrosine phosphatase Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A4HSE7
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 11 |
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0006631 | fatty acid metabolic process | 4 | 11 |
GO:0006633 | fatty acid biosynthetic process | 5 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008610 | lipid biosynthetic process | 4 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016053 | organic acid biosynthetic process | 4 | 11 |
GO:0019752 | carboxylic acid metabolic process | 5 | 11 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 11 |
GO:0043436 | oxoacid metabolic process | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 11 |
GO:0044255 | cellular lipid metabolic process | 3 | 11 |
GO:0044281 | small molecule metabolic process | 2 | 11 |
GO:0044283 | small molecule biosynthetic process | 3 | 11 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 1 |
GO:0006643 | membrane lipid metabolic process | 4 | 1 |
GO:0006665 | sphingolipid metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 1 |
GO:0030497 | fatty acid elongation | 6 | 1 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 1 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0016829 | lyase activity | 2 | 11 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 11 |
GO:0016836 | hydro-lyase activity | 4 | 11 |
GO:0102158 | very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity | 5 | 11 |
GO:0102343 | obsolete 3-hydroxy-arachidoyl-CoA dehydratase activity | 5 | 11 |
GO:0102344 | obsolete 3-hydroxy-behenoyl-CoA dehydratase activity | 5 | 11 |
GO:0102345 | obsolete 3-hydroxy-lignoceroyl-CoA dehydratase activity | 5 | 11 |
GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 208 | 210 | PF00675 | 0.253 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.253 |
DEG_APCC_DBOX_1 | 124 | 132 | PF00400 | 0.399 |
DEG_MDM2_SWIB_1 | 177 | 185 | PF02201 | 0.296 |
DOC_CYCLIN_yClb1_LxF_4 | 172 | 177 | PF00134 | 0.296 |
DOC_MAPK_gen_1 | 162 | 171 | PF00069 | 0.278 |
DOC_MAPK_MEF2A_6 | 97 | 104 | PF00069 | 0.320 |
DOC_PP1_RVXF_1 | 172 | 178 | PF00149 | 0.296 |
DOC_PP1_RVXF_1 | 95 | 102 | PF00149 | 0.288 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.293 |
DOC_USP7_UBL2_3 | 210 | 214 | PF12436 | 0.499 |
DOC_WW_Pin1_4 | 65 | 70 | PF00397 | 0.362 |
LIG_14-3-3_CanoR_1 | 115 | 119 | PF00244 | 0.293 |
LIG_14-3-3_CanoR_1 | 135 | 143 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 208 | 213 | PF00244 | 0.456 |
LIG_14-3-3_CterR_2 | 219 | 224 | PF00244 | 0.613 |
LIG_Actin_WH2_2 | 119 | 137 | PF00022 | 0.273 |
LIG_BRCT_BRCA1_1 | 97 | 101 | PF00533 | 0.253 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.318 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.151 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.337 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.390 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.151 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.278 |
LIG_LIR_Gen_1 | 137 | 147 | PF02991 | 0.309 |
LIG_LIR_Gen_1 | 180 | 190 | PF02991 | 0.277 |
LIG_LIR_Gen_1 | 72 | 82 | PF02991 | 0.332 |
LIG_LIR_Gen_1 | 98 | 107 | PF02991 | 0.286 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 137 | 142 | PF02991 | 0.260 |
LIG_LIR_Nem_3 | 178 | 182 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 184 | 190 | PF02991 | 0.269 |
LIG_LIR_Nem_3 | 197 | 201 | PF02991 | 0.226 |
LIG_LIR_Nem_3 | 38 | 43 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.359 |
LIG_LYPXL_S_1 | 39 | 43 | PF13949 | 0.511 |
LIG_LYPXL_yS_3 | 40 | 43 | PF13949 | 0.298 |
LIG_PALB2_WD40_1 | 182 | 190 | PF16756 | 0.318 |
LIG_Pex14_2 | 177 | 181 | PF04695 | 0.270 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.318 |
LIG_SH2_CRK | 85 | 89 | PF00017 | 0.407 |
LIG_SH2_STAP1 | 136 | 140 | PF00017 | 0.529 |
LIG_SH2_STAP1 | 201 | 205 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.270 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.275 |
LIG_SH3_3 | 138 | 144 | PF00018 | 0.293 |
LIG_SH3_3 | 166 | 172 | PF00018 | 0.253 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.327 |
LIG_SUMO_SIM_anti_2 | 79 | 85 | PF11976 | 0.317 |
LIG_TYR_ITIM | 83 | 88 | PF00017 | 0.318 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.625 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.320 |
MOD_CK2_1 | 212 | 218 | PF00069 | 0.484 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.253 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.338 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.292 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.522 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.293 |
MOD_N-GLC_1 | 175 | 180 | PF02516 | 0.476 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.441 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.278 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.569 |
MOD_PKA_1 | 208 | 214 | PF00069 | 0.456 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.293 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.440 |
MOD_PKA_2 | 208 | 214 | PF00069 | 0.456 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.271 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.220 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.459 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.329 |
MOD_Plk_4 | 181 | 187 | PF00069 | 0.323 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.319 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.305 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.293 |
MOD_Plk_4 | 95 | 101 | PF00069 | 0.313 |
MOD_ProDKin_1 | 65 | 71 | PF00069 | 0.362 |
TRG_DiLeu_BaLyEn_6 | 42 | 47 | PF01217 | 0.276 |
TRG_DiLeu_BaLyEn_6 | 77 | 82 | PF01217 | 0.318 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.275 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.292 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.377 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.298 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.318 |
TRG_ER_diLys_1 | 221 | 224 | PF00400 | 0.637 |
TRG_NLS_MonoExtC_3 | 161 | 166 | PF00514 | 0.272 |
TRG_NLS_MonoExtN_4 | 159 | 166 | PF00514 | 0.272 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HT96 | Leptomonas seymouri | 77% | 100% |
A0A0S4J5C4 | Bodo saltans | 53% | 100% |
A0A1X0P0I0 | Trypanosomatidae | 63% | 94% |
A0A3R7K8T2 | Trypanosoma rangeli | 61% | 93% |
A0A3S5H5H0 | Leishmania donovani | 100% | 100% |
A2AKM2 | Mus musculus | 27% | 97% |
A4H472 | Leishmania braziliensis | 85% | 100% |
B0YJ81 | Homo sapiens | 35% | 78% |
D0A4J7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 80% |
E9AKD3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
O14346 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 100% |
O17040 | Caenorhabditis elegans | 37% | 100% |
P40857 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 33% | 100% |
Q0P5C7 | Bos taurus | 23% | 97% |
Q2KIP8 | Bos taurus | 39% | 88% |
Q4QJH5 | Leishmania major | 96% | 100% |
Q4W1W1 | Canis lupus familiaris | 36% | 90% |
Q5RBK3 | Pongo abelii | 39% | 88% |
Q5VWC8 | Homo sapiens | 25% | 97% |
Q5ZEJ0 | Oryza sativa subsp. japonica | 39% | 100% |
Q6GNB5 | Xenopus laevis | 26% | 100% |
Q6Y1H2 | Homo sapiens | 39% | 88% |
Q7XSZ4 | Oryza sativa subsp. japonica | 40% | 100% |
Q8VZB2 | Arabidopsis thaliana | 41% | 100% |
Q9D3B1 | Mus musculus | 39% | 88% |
Q9N1R5 | Ovis aries | 36% | 78% |
Q9QY80 | Mus musculus | 36% | 80% |